Andere talen Black Diamond Therapeutics, Inc.

Aandelen

BDTX

US09203E1055

Geschatte realtime Cboe BZX Andere beurzen 18:28:08 08-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
7,02 ^USD	-2,50%		+20,34%	+152,67%

11/04	Black Diamond Therapeutics, Inc. Kondigt wijzigingen in de raad van bestuur en comités aan	CI
08/04	BLACK DIAMOND THERAPEUTICS, INC. : Wedbush geeft koopadvies	ZM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Black Diamond Therapeutics Announces Presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	24/04
Black Diamond Therapeutics, Inc. Announces Board and Committee Changes	11/04
Black Diamond Therapeutics Announces Changes to Board of Directors	11/04
Black Diamond Therapeutics Says BDTX-1535 Potentially Inhibits Non-Classical Mutations in Non-Small Cell Lung Cancer Patients	08/04
Black Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Association of Cancer Research Annual Meeting	08/04
Black Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Association of Cancer Research Annual Meeting	08/04
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences	03/04
Black Diamond: Q4 Earnings Snapshot	12/03
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	12/03
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	12/03
Black Diamond Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	12/03
Black Diamond Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	12/03
Black Diamond Therapeutics Announces Upcoming Presentation at AACR Annual Meeting 2024	05/03
Black Diamond Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference	28/02
Black Diamond Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference	28/02
Black Diamond Therapeutics, Inc. Announces Resignation of Rajeev Shah from Board of Directors, Including as A Member of the Audit Committee of the Board	18/01
Black Diamond Therapeutics Announces Corporate Update and Expected 2024 Milestones	04/01
Black Diamond Therapeutics Announces Corporate Update and Expected 2024 Milestones	04/01
Black Diamond Therapeutics Announces Topline Results from Phase 1 Dose Escalation Trial of BDTX-1535 in Patients with Recurrent GBM	13/12
Black Diamond Therapeutics, Inc. Announces Topline Results from Phase 1 Dose Escalation Trial of BDTX-1535 in Patients with Recurrent GBM	13/12

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Black Diamond Therapeutics, Inc.

Aandelen

BDTX

US09203E1055

Andere talen

Filters